Position in DGX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$836,354
+$335,430 QoQ
Shares Held
3,946
+54.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#520
of 1,090 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $8,695,472 across 10 Diagnostics & Research names. DGX ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
5,016 | $2,656,423 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
3,112 | $1,638,281 | |
| 3 | ILMN |
Illumina, Inc.
|
6,425 | $1,129,707 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
1,964 | $984,671 | |
| 5 | DGX |
Quest Diagnostics Inc
This page
|
3,946 | $836,354 | |
| 6 | A |
Agilent Technologies, Inc.
|
3,232 | $429,306 | |
| 7 | DHR |
Danaher Corp /De/
|
2,131 | $405,912 | |
| 8 | CSTL |
Castle Biosciences Inc
|
15,932 | $379,978 |
All Filings in DGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $836,354 | 3,946 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $500,924 | 2,556 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $576,987 | 3,325 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $593,084 | 3,112 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $557,032 | 3,101 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $234,680 | 1,387 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||